Results 171 to 180 of about 207,511 (311)
Scoping review of clinical signs, etiologies, pathology findings, risk factors, and treatments of acute interstitial pneumonia in North American feedlot cattle. [PDF]
Schmidt PH +3 more
europepmc +1 more source
Objective Beyond its role as a ribosome‐targeting antibiotic, linezolid was recently shown to modulate immune responses by inhibiting mitochondrial translation. Because mitochondrial dysfunction is implicated in various fibrotic diseases, including systemic sclerosis (SSc), this study aimed to evaluate the antifibrotic potential of linezolid and ...
Xuezhi Hong +13 more
wiley +1 more source
Beyond Chronological Age: Aging and Senescence in Interstitial Lung Diseases. [PDF]
Hernández-Marcos M +3 more
europepmc +1 more source
Objective Mitochondria are organelles with a hypomethylated circular genome. Mitochondrial DNA (mtDNA) in the systemic circulation has been implicated in inflammation. This study investigates the role of circulating DNA in systemic sclerosis (SSc) and the cellular mechanisms governing its release.
Stavros Giaglis +9 more
wiley +1 more source
From Silicosis to Scleroderma: Erasmus Syndrome
María Belén Noboa +4 more
doaj +1 more source
Predictors of Progressive Fibrosing Interstitial Lung Diseases and Survival in Fibrosing Interstitial Lung Disease-Related Usual Interstitial Pneumonia. [PDF]
Fu H, Li X, Shi H, Zhang J, Zhang M.
europepmc +1 more source
Objective High‐intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced systemic sclerosis (SSc). The role of reduced‐intensity conditioning (RIC) before AHSCT in this population remains unclear.
Yonatan Lean +4 more
wiley +1 more source
Rationale and design of uLtrasOund applicability in the assessment of patients with fibRosing interstitial lung Disease (LORD): a research protocol of a prospective cohort study. [PDF]
Patabendige S +9 more
europepmc +1 more source
Background The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasing immunosuppressive (IST) and anti‐fibrotic therapies available. However, their real‐world use remains unclear. Objectives To analyze treatment trends and the effect of IST and anti‐fibrotic therapies on ILD progression ...
Corrado Campochiaro +17 more
wiley +1 more source
A multidisciplinary diagnostic approach to pulmonary fibrosis in dogs and cats. [PDF]
Reinero CR, Masseau I, Williams KJ.
europepmc +1 more source

